Quick Answer
ARTELO BIOSCIENCES, INC. reported Operating Income of -$11.40 million for fiscal year 2025.
ARTELO BIOSCIENCES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$11.40M | -12.8% |
| 2024 | -$10.11M | -1.8% |
| 2023 | -$9.93M | +3.5% |
| 2022 | -$10.29M | -9.2% |
| 2021 | -$9.42M | -26.6% |
| 2021 | -$7.44M | -58.8% |
| 2020 | -$4.69M | -46.0% |
| 2019 | -$3.21M | -37.0% |
| 2018 | -$2.34M | -906.7% |
| 2017 | -$232.8K | -684.1% |
| 2016 | -$29.7K | -94.8% |
| 2015 | -$15.2K | +0.2% |
| 2014 | -$15.3K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.09M | -158.5% | +1.9% |
| June 30, 2025 | -$3.15M | -25.4% | -32.4% |
| March 31, 2025 | -$2.38M | +8.1% | -99.1% |
| September 30, 2024 | -$1.20M | +54.3% | +52.4% |
| June 30, 2024 | -$2.51M | -40.8% | +3.0% |
| March 31, 2024 | -$2.59M | -13.0% | +1.0% |
| September 30, 2023 | -$2.61M | -9.2% | -46.5% |
| June 30, 2023 | -$1.78M | +27.8% | +22.2% |
- ARTELO BIOSCIENCES, INC. showed a decrease of -12.8% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, ARTELO BIOSCIENCES, INC.’s operating income has declined by 74587.3% (from -$15.3 thousand to -$11.40 million).
- The most recent figure is from ARTELO BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: